ERIS Lifesciences will acquire 100% stake in Oaknet Healthcare at an equity valuation of Rs 650 crore. The business will be housed in Eris Oaknet Healthcare, a wholly owned subsidiary of the company. The deal is expected to be completed before end of May 2022. The acquisition facilitates the entry of Eris into the dermatology segment.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
